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Visceral Pleural Invasion: Pathologic Criteria and Use of
Elastic Stains
Proposal for the 7th Edition of the TNM Classification for
Lung Cancer
William D. Travis, MD,* Elisabeth Brambilla, MD,† Ramon Rami-Porta, MD,‡ Eric Vallie`res, MD,§
Masahiro Tsuboi, MD, Valerie Rusch, MD,¶ and Peter Goldstraw, FRCS#;
on behalf of the International Staging Committee
Objective: To define the anatomic extent of visceral pleural inva-
sion (VPI) and to assess whether elastic stains are useful to deter-
mine VPI in lung cancer. The elastic layer of the visceral pleura is
not mentioned in the current International Union Against Cancer or
American Joint Committee on Cancer staging documents.
Methods: A Pub Med search (www.pubmed.gov) of the National
Library of Medicine was made for all articles published between
1970 and 2007 in humans under the search terms lung cancer and
pleural invasion. These were reviewed for data regarding the patho-
logic classification of extent of pleural invasion including the use of
elastic stains in this assessment.
Results: Six articles that addressed reported survival data using
elastic stains to assess for VPI were reviewed. These articles defined
P0 (T1) as lack of pleural invasion beyond the elastic layer, P1 (T2)
as invasion beyond the elastic layer, P2 (T2) as invasion to the
surface of the visceral pleura and P3 (T3) as invasion of the parietal
pleura. In five studies, survival was shown to be significantly worse
for VPI defined as P1 or P2 compared with P0.
Conclusions: Based on the currently available data, we propose that
the next tumor, node, metastasis (TNM) revision by International
Union Against Cancer and American Joint Committee on Cancer
define VPI as invasion beyond the elastic layer (PL1) including
invasion to the visceral pleural surface (PL2). The abbreviation PL
for pleura is recommended rather than P to avoid confusion with the
existing use of p (pathologic) TNM in distinction from c (clinical)
TNM. We also recommend that elastic stains be used in cases when
the distinction between PL0 and PL1 is not clear based on evaluation
of hematoxylin and eosin sections.
Key Words: Visceral pleural invasion, Lung cancer, Stage, Elastic
stain, Pathology, Pleura.
(J Thorac Oncol. 2008;3: 1384–1390)
The anatomic extent of disease, as expressed by the tumor,node, metastasis (TNM) staging system, is the most
important prognostic factor for lung cancer. Visceral pleural
invasion (VPI) increases the T staging factor from T1 to T2
and upstages a tumor, even if less than 3 cm in size, from
Stage IA to IB according to the TNM staging system for lung
cancer by the 6th editions of the International Union Against
Cancer (UICC) and American Joint Committee on Cancer
(AJCC).1,2 This is important because adjuvant chemotherapy
is sometimes considered for patients following complete
resection for Stage IB non-small cell lung carcinoma
(NSCLC) but has not been shown to be of value in Stage IA
NSCLC.3 However, a precise definition of VPI is not pro-
vided in either the UICC or AJCC publications. In the UICC
TNM Supplement, it is stated that “invasion of the visceral
pleura (T2) includes not only perforation of the mesothelium,
but also invasion of the lamina propria serosae.”4 This doc-
ument does not provide criteria for what is invasion of the
“lamina propria serosae” and whether this bears any relation-
ship to the elastic layer of the visceral pleura. The elastic
layer of the visceral pleura is not specifically mentioned in
either the UICC or AJCC documents. In recent years, the use
of elastic stains has been recommended for defining VPI.
While this is becoming more accepted, there remains contro-
versy regarding whether tumors that invade beyond the elas-
tic layer but not to the pleural surface should be regarded as
T1 or T2.5–7
In 1988, Hammar, suggested a classification of pleural
invasion that defined P0 as lack of pleural invasion beyond
the elastic layer, P1 as invasion beyond the elastic layer, P2
as invasion to the surface of the visceral pleura and P3 as
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invasion of the parietal pleura and/or chest wall.5,8 Hammar
also included a category of Px that applied to tumors situated
within the lung parenchyma with no relationship to the
pleura. According to this scheme, P0 corresponds to T1, P1 or
P2 correspond to T2 and P3 corresponds to T3. This approach
has been used by several recent studies (Table 1) and the
same levels of pleural invasion (except for Px) are recognized
by the Japan Lung Cancer Society.6 However, according to
the Japan Lung Cancer Society, it is required that the tumor
invade to the surface of the visceral pleura (P2) to qualify for
T2 and tumors that invade beyond the elastic layer but not to
the pleural surface (P1) remain T1.6 In one study, visceral
pleural involvement was defined as tumor extending to within
1 mm of the visceral pleural margin or involving the margin.9
So there is need for some clarification of the definition of
pleural invasion in the staging of lung cancer.
Many pathologists are not inclined to do elastic stains
in assessing the pleura for VPI. In a survey of lung cancer
surgical pathology reports from the year 1991 performed by
the College of American Pathologists (CAP), Gephardt et
al.10 found that VPI was addressed in only 65% of cases.
However, more recently Taube et al.11 surveyed members of
the American Association of Directors of Anatomic and
Surgical Pathology who consist of many of the leaders in the
field of surgical pathology. Of 49 pathologists who re-
sponded, 51% never use elastic stains, 29% use them some-
times, and 20% use them routinely to assess for VPI in lung
cancer specimens. Butnor et al.12 recently used an internet
based questionnaire to assess interobserver variability for VPI
with a set of photomicrographs of the pleura with elastic
stains in lung cancer specimens. The kappa statistic for
agreement was “fair” with a value of 0.35. The majority of
participants regarded invasion of the elastic layer as neces-
sary for VPI.
In preparation for the Seventh edition of the UICC and
AJCC TNM Classification for lung cancer staging, a series of
white papers are being published by the International Asso-
ciation for the Study of Lung Cancer staging committee.13–18
Extensive statistical analysis of data from 67,725 cases of
NSCLC submitted to the project forms the basis for most of
the recommendations. As there was no detailed pathologic
information regarding VPI submitted to the project the T
Factor Committee was unable to perform an analysis of
primary data on this subject. Because VPI is becoming
established as an important T factor for lung cancer, this
article makes recommendations regarding pathologic as-
TABLE 1. Survival of NSCLC by Assessment of Viscral Pleural Invasion Using Elastic Stains
Author, Year
Resected NSCLC Cases
Studied
Frequency of
VPI Definition of VPI Survival Data Favor Elastic Stains
Bunker ML 199938 26 P0: 12 (46%) P1:
8 (31%) P2: 6
(23%)
Hammar method5 Significantly worse survival
with greater degrees of
pleural involvement (p 
0.0000)
Yes
Manach 200129 1281 430 T1: 851 T2 VPI: n  245
(19%)
Hammar method5 Significantly worse 5 & 10 yr
survival in VPI (35% and
28%) compared to no VPI
(52% and 34%), P 
0.000002; VPI also
independent factor in
multivariate analysis
Yes
Kang JH 200328 439 T2: 234 IB; 95 IIB,
110 IIIA & B
VPI: 114 (26%) Hammar method5 VPI assoc higher frequency of
N2 or N3 (p  0.009) VPI
worse survival: (p 
0.0006) even with
multivariate analysis
Yes
Osaki T 200430 474 T1 & T2 P0: 345 (73%) P1:
110 (23%) P2:
19 (4%) VPI in
129 (27%)
Hammar method5 Degree of VPI independent
prognostic factor by
multivariate analysis (p 
0.033); P1 & P2 worse
than p0, but survival for P1
vs. P2 not different
Yes Recommend P1
and P2 be
designated as T2
Shimizu K 20047 1653 T1, T2 and T3 P0:1055 (64%) P1:
271 (16%) P2:
81 (5%) T3: 246
(15%) VPI in
352 (21%)
Japanese Lung Cancer
Society6
Survival identical for P1 or
P2–significantly worse than
for P0 disease for either
3 cm or 3 cm Worse
survival for P1/P2 vs. P0
Yes Data supports p0
as non-VPI and P1
or P2 as VPI
Shimizu K 200531 1704 T1 and T2 VPI in 288 (27%) Japanese Lung Cancer
Society6
But used P0* as non-
VPI and P1 or P2 as
VPI similar to
Hammar
5 & 10 yr survival
No VPI: 76 & 53% vs.
VPI: 50 and 37% (p 
0.0001) VPI also significant
by multivariate analysis
Yes VPI significant
and independent for
prognosis
VPI, visceral pleural invasion; yr, year; NSCLC, non-small cell lung cancer.
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sessment of the pleura based on analysis of data in the
existing literature. The goal is to define pleural invasion in
a manner that will allow for accurate collection of data
regarding this important T factor for future analysis in a
prospective database.
PATIENTS AND METHODS
A Pub Med search (www.pubmed.gov) of the National
Library of Medicine was made for all articles published
between 1970 and 2007 in humans under the search terms
lung cancer and pleural invasion. These were reviewed for
data regarding the pathologic classification of extent of pleu-
ral invasion including the use of elastic stains in this assess-
ment. Studies with survival data on all NSCLC with at least
25 cases where elastic stains were used to assess for VPI
using the criteria of either Hammar5 or the Japan Lung
Cancer Society6 are summarized in Table 1. In addition
standard documents such as the UICC TNM 6th Edition1
including the TNM Supplement,4 AJCC Staging documents,2
and protocols for the processing of lung cancer specimens
from the CAP,19,20 Association of Directors of Anatomic and
Surgical Pathology,21 the AJCC and Department of Health
and Human Services Collaborative Staging Manual,22 and
Royal College of Pathologists were reviewed.23 In addition
several recent reviews on the topic of pathology reporting of
lung cancer specimens and VPI were reviewed.24–27
RESULTS
One hundred ninety nine articles were obtained in the
PubMed search. Although there were many articles with data
addressing the issue of VPI, of those that met the above
criteria, there were six articles that addressed reported sur-
vival data with respect to assessment of the visceral pleura
using elastic stains for staging of lung cancer. Each of these
articles reported data that supports the use of elastic stains in
documenting VPI in cases where the status of invasion is
indeterminate based on review of hematoxylin and eosin
(H&E) stained sections.
In five studies, survival was shown to be significantly
worse for VPI defined as P1 or P2 compared with P0
according to the Hammar criteria.7,28–31 In only two studies
by Shimizu et al.,7 and Osaki et al.,30 data were analyzed
comparing P1 versus P2 levels of pleural invasion and both
showed no difference in survival.
Review of current documents for lung cancer specimen
processing from the CAP,19,20 Association of Directors of
Anatomic and Surgical Pathology,21 the AJCC/Department of
Health and Human Services Collaborative Staging Manual,22
and the Royal College of Pathologists, revealed that only the
Royal College of Pathologists specifically recommends that
elastic stains may be helpful in recognition of pleural inva-
sion.23 An upcoming revised version of the CAP lung cancer
guidelines states that VPI should include tumors that pene-
trate beyond the elastic layer of the visceral pleura and that
elastic stains may aid in the assessment of pleural invasion.32
The 2000 Classification of Lung Cancer by the Japanese
Lung Cancer Society defines p1 as “invasion beyond the
visceral elastic pleura, but limited to the pulmonary pleura”
and p2 as “definite invasion to the surface of the pulmonary
pleura”. However, they require p2 for classification of T2 so
p1 remains T1.6
Several recent reviews of lung cancer pathology spec-
imen evaluation point out the need for more accurate assess-
ment of the pleura with the use of elastic stains to assess for
VPI.24–27
DISCUSSION
Proposal for Classification of VPI in TNM
Revision
Based on the currently available data, we propose that
the next TNM revision by UICC and AJCC define VPI as
invasion beyond the elastic layer (Figure 1). We also suggest
a slight modification of the Hammar diagram of the pleura
with designations of PL for pleura, rather than P, which is
also used by TNM for designation of pathologic versus
clinical staging. Therefore PL0 represents either tumor within
FIGURE 1. Modified Hammar Classification48 of visceral
pleural invasion (VPI) for lung cancer. The different clusters
of blue cells represent tumors with varying levels of VPI. PL0
represents either tumor within the subpleural lung paren-
chyma or invading superficially into the pleural connective
tissue beneath the elastic layer. If a tumor invades beyond
the elastic layer it is PL1. Tumors that invade to the pleural
surface are PL2 and those that invade into any component
of the parietal pleura are PL3. PL0 is not regarded as a T de-
scriptor and the T category should be assigned on other fea-
tures. PL1 or PL2 indicate VPI and are a T2 descriptor. PL3
indicates invasion of the parietal pleura and is a T3 descrip-
tor. Reprinted with permission from Aletta Ann Frazier, MD.
Any reproduction of the Licensed Products in any format,
including all print and electronic formats and in agreement
with the full extent of the License, shall be accompanied by
artist name attribution and copyright notice directly adjacent
to the image and in the form: Copyright © 2008 Aletta Ann
Frazier, MD.
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the subpleural lung parenchyma or invading superficially into
the pleural connective tissue beneath the elastic layer. If a
tumor invades beyond the elastic layer it is PL1. Tumors that
invade to the pleural surface are PL2 and those that invade
into any component of the parietal pleura are PL3. PL0 is not
regarded as a T descriptor and the T category should be
assigned on other features. PL1 or PL2 indicate VPI and are
a T2 descriptor. PL3 indicates invasion of the parietal pleura
and is a T3 descriptor. In addition, we recommend that the Px
category proposed by Hammar, be discontinued in this con-
text, and if used at all, be reserved for use as the “x” category
is used elsewhere in the TNM classification, i.e., where the
PL category is unknown (PLx).
If a tumor achieves T2 status based on VPI, and it is 5
cm or less in size it is classified as T2a. If such a tumor is
greater than 5 cm but 7 cm or less in size it is T2b. If it is
larger than 7 cm it becomes T3.
We also recommend that elastic stains be used in cases
where it is difficult to distinguish PL0 from PL1 status on
review of H&E stains for VPI. It is the thick elastic layer
within the visceral pleura that should be invaded. The loca-
tion of this thick elastic layer is variable sometimes being
situated close to the alveolar parenchyma and in other cases
being closer to the middle of the visceral pleural connective
tissue. The tumor needs to cross beyond this thick elastic
layer for PL1 classification. In some cases there is a percep-
tible connective tissue layer between the lung parenchyma
and the thick elastic layer; invasion of this connective
tissue that falls short of traversing the elastic layer is
regarded as PL0. A tumor remains classified as PL0 if
tumor cells intermingle with elastic fibers without pene-
tration beyond the elastic layer. In some cases the elastic
fibers can be visualized on H&E by lowering the micro-
scope condenser. However, the elastic layer is often com-
pletely imperceptible on H&E and only visualized with
elastic stains; these cases are regarded as “indeterminate
for VPI” on H&E alone. In difficult cases where the
visceral pleura elastic layer is not clearly discernable or
there is prominent reduplication of the elastic fibers, one
has to apply General Rule 4 of the TNM classification and
assign the lower category in such circumstances.33
Histologic assessment of the pleura with elastic stains
should be performed on the histologic section(s) where there
is the greatest concern for VPI. Histologic sampling of the
pleura in the lung cancer resection specimen should be
obtained in the area where there is the greatest concern for
invasion by gross examination.
Rationale for Assessment of VPI
There are multiple studies demonstrating the prognostic
significance of VPI in NSCLC,7,28–31,34 especially those that
use the Hammar method for evaluating lung cancer speci-
mens for VPI.7,28–31 The studies by Kang et al., Manac’h et
al., Osaki et al., and Shimizu et al. reported that VPI corre-
lated with worse survival even in multivariate analysis.28–31
Kang et al. also demonstrated that VPI was an adverse
prognostic factor in T2 NSCLC and it correlated with more
extensive mediastinal lymph node involvement.28 Shimizu et
al. showed that VPI was a significant independent adverse
prognostic factor in NSCLC with or without lymph node
metastases.31
Several older studies suggest there is no impact of VPI
on survival in small, early stage NSCLC.35,36 However,
neither the Padilla nor Martini studies used either the detailed
Hammar approach to pathologic assessment or elastic stains
to evaluate the specimens for VPI.35,36 Furthermore, the
Padilla study only had 158 patients35 and the Martini study of
598 Stage I NSCLC found VPI had a p value of 0.06 which
is close to being significant for overall survival.36 In a recent
paper, Ou et al.37 report data from the California Cancer
Registry that suggest that VPI carries an increased risk of
mortality and that it may vary depending on tumor size.
However, in this study the Surveillance, Epidemiology, and
End Results code EOD40 does not distinguish between VPI,
hilar atelectasis or obstructive pneumonitis, so VPI could not
be specifically analyzed.37 In addition, there are limited data
regarding the question whether there is a difference in the
significance of VPI as an adverse prognostic factor according
to tumor size with a greater significance to VPI in larger (3
cm) compared with smaller (3 cm) tumors.7,36 While Mar-
tini et al.36 did not find VPI to be a significant adverse
prognostic factor in Stage I NSCLC overall, in tumors over 3
cm in size it was significant. Shimizu et al. suggested that VPI
in a tumor larger than 3 cm should be classified as T3 rather
than T2 as recommended by the previous Sixth Editions of
the UICC and AJCC staging systems and the revision pro-
posal by the International Association for the Study of Lung
Cancer (IASLC) staging committee.1,2,7,13,16 However,
Shimizu et al.7 found that VPI significantly correlated with
worse outcome in tumors smaller than 3 cm. The IASLC
Staging committee choose to give equal weight to the nonsize
T2 factors of (1) VPI, (2) involving the main bronchus 2 cm
or more distal to the carina and atelectasis or (3) obstructive
pneumonitis that extends to the hilar region but does not
involve the entire lung.13,16 The question of the effect of
tumor size on the impact of VPI remains to be determined in
studies of larger numbers of cases such as the prospective
IASLC database.
Usefulness of Elastic Stains
In most cases an elastic stain is not needed to assess the
pleura for invasion. Only in cases where the distinction
between PL0 and PL1 is unclear on H&E sections, is an
elastic stain needed. Elastic stains may also be helpful in
cases where the visceral and parietal pleura are adherent,
making it difficult to know where is the visceral pleural
surface and the parietal pleura. The usefulness of elastic
stains for VPI has been emphasized recently by Taube et al.11
who in a series of 100 NSCLC smaller than 3 cm in size,
demonstrated that VPI could be identified in 19% of cases
where no VPI was seen on H&E stains only. Therefore these
tumors were changed from Stage IA to Stage IB. They also
found VPI occurred in all histologic types of NSCLC except
for bronchioloalveolar carcinoma.11 Bunker et al.38 found in
a series of 26 cases that the use of elastic stains changed the
pathologic stage in 1 case or 4% of lung cancers overall. They
also found penetration of the elastic layer in 8/20 cases (40%)
that were indeterminate for pleural invasion and were missed
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on examination of routine H&E sections. However, because
of other T factors, this only increased the stage from T1 to T2
in 1/20 cases (5%).38 In 1/20 cases (5%), the use of elastic
van Gieson stains helped to exclude VPI that had been
overcalled on H&E, so it decreased the stage from T2 to T1.38
In summary, among the 20 cases indeterminate for VPI on
H&E examination, Bunker et al.38 found that elastic stains for
VPI changed the overall assessment of VPI in 9/20 (45%) of
cases (8 cases T1 to T2, 1 case T2 to T1), however, because
of other T factor status, the actual T stage for the patient
changed in only 2/20 (10%) cases.
Several types of elastic stains can be used including
Verhoeff’s elastic van Gieson stain, Elastin hematoxylin and
eosin, Weigert’s elastic stain, and the Movat or pentachrome
stain.39 The decision on which stain to use is largely a factor
of which one the histology staff and pathologists are the most
comfortable performing and interpreting, respectively.
Anatomy of the Pleura
To best assess VPI in lung cancer specimens, it is
helpful to consider the microscopic anatomy of the visceral
pleura. For the purpose of evaluating the visceral pleura for
VPI, if a tumor invades past the elastic layer that is closer to
the alveolar lung parenchyma then it is classified as PL1 (T2);
if it does not penetrate this elastic layer, it is PL0 (T1). The
visceral pleural anatomy has previously been described to
have five layers that are best appreciated with elastic
stains.5,38,40 However, there is some variation in the number
and composition of tissue layers in the visceral pleura and
most commonly there are only four layers that can reliably be
identified. In general, moving from the visceral pleural sur-
face to the lung parenchyma, the visceral pleura consists of:
(1) a single layer of mesothelial cells resting on a basement
membrane, (2) a submesothelial connective tissue layer, (3)
elastic fibers that usually form a single prominent layer, but
may also form a second discontinuous layer (the fifth layer
sometimes described) with varying amounts of fibrous con-
nective tissue between the 2 elastic layers, (4) a connective
tissue layer of varying thickness that separates the elastic
layer from the lung parenchyma which is demarcated by a
layer of pneumocytes resting on a thin basement membrane
(Figure 1). So the number of layers in the visceral pleura may
vary from four to six. The thick elastic fiber layer is regarded
as the demarcation between PL0 and PL1. So if a tumor
invades the connective tissue of the pleura below the thick
elastic layer without penetrating it, the tumor is classified as
PL0. The articles cited in Table 1 that report data supporting
the use of elastic stains for assessment of VPI do not refer to
more than one elastic layer, so their results are consistent with
our recommendation of using the thick elastic layer as the
limit between PL0 and PL1, regardless of whether it is closer
to the lung or the visceral pleural surface. If there happens to
be two thick elastic layers, if the one nearest the lung
parenchyma is penetrated, this would qualify as PL1.
The anatomy of the parietal pleura is more variable than
the visceral pleura. In general it is covered by a mesothelial
layer that rests upon a basement membrane and a thin layer of
loose connective tissue. This is followed by a discontinuous
elastic layer, then another layer of loose connective tissue.
Below this lies a dense collagenous layer or endothoracic
fascia that may have varying amounts of fat on both sides and
after this are the skeletal muscle fibers of the chest wall. A
tumor is classified as PL3 (T3) if it invades any of the
anatomic structures of the parietal pleura. There is no data
evaluating lung cancer survival according to different levels
of invasion of the parietal pleura. Given the variability of the
parietal pleural anatomy, this may be difficult to achieve.
Problems in Interpretation of Elastic Stains
Elastic stains are very helpful in distinguishing some
cases of PL0 from PL1 VPI, but they do not solve all difficult
problems. There are a number of problematic issues that need
to be considered in evaluating the visceral pleura for inva-
sion. The normal visceral pleura anatomy shows some degree
of variation; however, significant anatomic alterations occur
when the pleura is affected by inflammation and fibrosis.
These changes are frequent in the setting of lung cancer
where the tumor is situated beneath the pleura or if it invades
the pleura. Pleural puckering is a common finding in sub-
pleural tumors, particularly adenocarcinomas. Gallagher et
al.41 pointed out that the visceral pleural elastic layer could be
invaded in 3 patterns: (1) without eliciting any secondary
changes, (2) with prominent elastic reduplication and inflam-
matory infiltrate, and (3) with thick fibroblastic proliferation.
It may be very difficult to assess for pleural invasion when
there is reduplication of elastic layer leading to many layers
of elastic fibers. When there is pleural puckering sometimes
VPI occurs in an area where the pleura invaginates into the
lung along an interlobular septa. Elastic stains can also help
to define VPI in cases where there are dense fibrous adhesions
between the visceral and parietal pleura causing fusion and
obliteration of the pleural space.
Invasion of the parietal pleura often is highlighted by
tumor growing into fat. Since fat can be present within the
connective tissue of the visceral pleura, especially when there
is underlying pulmonary fibrosis, the presence of tumor cells
within fat should not be assumed to represent parietal pleural
invasion unless the surgical specimen includes parietal pleura
in the area being examined.
Problems with the Interlobar Fissure
According to the current TNM “a tumor with local
invasion of another ipsilateral lobe without tumor on the
visceral pleural surface should be classified as T2.”4 In
contrast, according to the 2000 Classification of Lung Cancer
by the Japanese Lung Cancer Society, “invasion of the
adjacent lobes where the interlobar borderline should be in
case with incomplete lobe formation should be recorded as
P0,” which is classified as T1.6 Unfortunately the data on this
point are not definitive as the few studies that address this
problem have small numbers of patients.42–44 Miura et al.43
report 18 patients including 8 that were N0M0, 6 N1M0 and
4 N2M0. They found the 5-year survival of 34% for these
patients was significantly better (p  0.001) than the 14% for
patients with parietal pleural invasion (PL3) and no different
from those with only VPI. Pneumonectomy was performed in
4, bilobectomy in 4, and lobectomy with parietal resection
with a “sufficient safety margin” was performed in 10 cases.
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Based on these data they recommended that invasion beyond
the interlobar pleura should be classified as T2. Two other
studies favored classification as T3. Demir et al.42 reported 60
of 351 NSCLC cases that had minimal invasion of the
adjacent lobe including 40 treated with pneumonectomy, 10
with bilobectomy, and 10 with lobectomy plus partial adja-
cent lobe resection. There were 23 N0, 29 N1, and 8 N2
patients in this group. Five year survival for the adjacent lobe
invasion group was 36% which was significantly poorer than
survival for T2 patients in multivariate analysis (p  0.049),
but not significantly different from survival of patients with
T3 patients. Therefore these authors recommended that inva-
sion beyond the interlobar pleura be classified as T3.42
Okada et al.44 reported 19 patients including 6 N0M0, 7
N1M0, and 6 N2M0 cases that showed a 5-year survival of
37%. Because this was similar to the 40% and 38% 5-year
survival for their patients with invasion of the parietal
pleura and chest wall, they recommended interlobar pleu-
ral invasion be classified as T3.44
These studies have not completely resolved this ques-
tion. Interestingly the 5-year survival is virtually identical in
each study (34–37%), but one study favors classification of
interlobar invasion as T2 and 2 studies favor T3. This is
complicated by the fact that in some cases with no fissure,
invasion of the adjacent lobe can occur across the lung
parenchyma without involvement of the visceral pleura. More
data from larger studies will be required to resolve whether
the T2 classification by the 6th edition of the UICC/AJCC
staging system1,2 or the T1 classification by the Japanese
Lung Cancer Society proposal (T1) are appropriate.6
Anatomic variation of the interlobar fissure can poten-
tially impact clinical and pathologic assessment of lung
cancers for involvement of adjacent lobe(s). This includes an
incomplete interlobar fissure45 or fusion of the adjacent
lobes.46 Craig et al.47 proposed a classification of pulmonary
fissures ranging from Grade 1 with a complete fissure with
entirely separate lobes, Grade 2 with complete visceral cleft
but parenchymal fusion at the base of the fissure, Grade 3
with a visceral cleft for part of the fissure and Grade 4 with
complete fusion of the lobes with no apparent fissural line.
Kamiyoshihara et al.45 found incomplete interlobar fissures in
74 (31%) of 239 NSCLC but there was no difference in
survival or recurrence compared with patients with complete
fissures. Nomori et al.46 addressed this problem from the
point of view of surgical technique when attempting video
assisted thoracoscopic surgical lobectomy and found this
approach to be satisfactory in most patients with largely fused
fissures. Determination of the appropriate T factor designa-
tion for invasion of adjacent lobes of lung cancers will require
careful attention by surgeons and pathologists to the status of
completeness or incompleteness of the interlobar fissures.
CONCLUSION
In the 7th edition TNM proposal we recommend the use
of a modified Hammar Classification for pathologic assess-
ment of VPI. VPI is defined as invasion beyond the elastic
layer (PL1) including invasion to the visceral pleural surface
(PL2). We also recommend the use of elastic stains when the
distinction between PL0 and PL1 is not clear based on
evaluation of H&E sections. Because of the impact of T1
versus T2 status on survival and the consequent discussions
regarding adjuvant chemotherapy after complete resection for
Stage IA versus IB NSCLC patients, the use of elastic stains
may be clinically important. Hopefully this recommendation
will result in more careful attention to pathologic assessment
of the visceral pleura in the evaluation of lung cancer spec-
imens. Study of larger numbers of cases with careful docu-
mentation of VPI will hopefully provide an answer to the
question whether size has any impact on the significance of
this T factor. Until sufficient data is available to address this
issue, our recommendation is to maintain the current TNM
recommendation that “a tumor with local invasion of another
ipsilateral lobe without tumor on the visceral pleural surface
should be classified as T2.”4 Hopefully these issues will be
resolved in the prospective IASLC lung cancer staging
project.
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